Identification of a new member of Mortaparib class of inhibitors that target mortalin and PARP1.

Front Cell Dev Biol · 2022 · PMC9510692 · PMID 36172283

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

extremely significantno p-value reported

highly significantno p-value reported

Values of p > 0.05 ( ns ), p ≤ 0.05 (*)‬, p ≤ 0.01 (**), p ‬≤ 0.001 (***) and p ‬ ≤ 0.0001 (****) were considered non-significant, statistically significant‬, very significant, highly significant, and extremely significant, respectively.

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.